Sivik Global Healthcare’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25,000
| Closed | -$6.77M | – | 42 |
|
|
2024
Q1 | $6.77M | Buy |
+25,000
| New | +$6.77M | 1.59% | 14 |
|
|
2023
Q3 | – | Sell |
-13,000
| Closed | -$2.73M | – | 39 |
|
|
2023
Q2 | $2.73M | Buy |
+13,000
| New | +$2.73M | 0.64% | 35 |
|
|
2022
Q3 | – | Sell |
-15,000
| Closed | -$3.21M | – | 42 |
|
|
2022
Q2 | $3.21M | Sell |
15,000
-5,000
| -25% | -$1.07M | 1.82% | 30 |
|
|
2022
Q1 | $5.68M | Buy |
20,000
+5,000
| +33% | +$1.42M | 2.34% | 18 |
|
|
2021
Q4 | $5.65M | Sell |
15,000
-5,000
| -25% | -$1.88M | 2.42% | 19 |
|
|
2021
Q3 | $8.25M | Sell |
20,000
-5,000
| -20% | -$2.06M | 1.97% | 16 |
|
|
2021
Q2 | $9.25M | Buy |
25,000
+2,500
| +11% | +$925K | 1.81% | 10 |
|
|
2021
Q1 | $6.52M | Buy |
22,500
+2,500
| +13% | +$725K | 2.38% | 23 |
|
|
2020
Q4 | $5M | Sell |
20,000
-5,000
| -20% | -$1.25M | 2.04% | 29 |
|
|
2020
Q3 | $5.66M | Buy |
+25,000
| New | +$5.66M | 2.43% | 23 |
|
|
2020
Q2 | – | Sell |
-15,000
| Closed | -$4.04M | – | 54 |
|
|
2020
Q1 | $4.04M | Buy |
+15,000
| New | +$4.04M | 1.59% | 30 |
|